Caicun Zhou
Shanghai thoracic oncologist and IASLC President, a leading investigator of targeted therapy for lung cancer in Asia.
Overview
Caicun Zhou is President of the International Association for the Study of Lung Cancer for the 2025-2027 term. He is a professor at Tongji University and Shanghai Pulmonary Hospital, where he has led many pivotal trials of EGFR-targeted therapies and immunotherapy in Chinese patients with non-small cell lung cancer. He is one of the most prolific lung cancer clinical investigators in China.
Pages like this
not linked directly; found by shared links- PersonKaren Kelly
Shares International Association for the Study of Lung Cancer, Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonMartin Schuler
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonAlexis Cortot
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonNobuyuki Yamamoto
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonAlfredo Addeo
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonHidetoshi Hayashi
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonSuresh S. Ramalingam
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
- PersonShun Lu
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags clinician-scientist, lung cancer.